Greenville, South Carolina, May 15, 2023 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing services, is pleased to announce that Mr. Bob Mann has been appointed President of ARCpoint Franchise Group LLC (“AFG”), a wholly owned US subsidiary of the Company that operates ARCpoint’s franchise business. Mr. Mann comes to AFG with over 20 years of successful leadership and innovation experience including 15 years in the US diagnostic services space. He will be responsible for driving both top line growth at all franchisee locations and growing the Company’s distribution network from the current 134 locations.
ARCPoint CEO John Constantine stated “Our top priority right now is to increase revenues by making it easier for customers to access and use our products and services, thereby removing sales impediments for our franchisees with their B2B customers, and at the same time driving more individual consumer traffic through franchisee locations. The key to our success in these endeavours will be the adoption of our new technology platform by both franchisees and consumers”.
The Company has now largely completed its new, integrated technology platform comprised of MyARCpointLabs and Total Reporting. The MyARCpointLabs portal for direct-to-consumer testing is an e-commerce platform that will make it much easier for individual customers to find and order the clinical tests that are available through the ARCpoint system. Total Reporting, the Company’s B2B portal, will allow ARCpoint’s franchisees to market more services through a more efficient, integrated platform that is much easier for B2B customers to use. Currently, about one-third of the AFG network has signed up and trained on the Total Reporting system. Deployment in initial locations of the Company’s consumer facing platform, MyARCpointLabs, is expected in the second quarter of 2023.
Mr. Constantine concluded, “For this reason, we are excited that Bob is joining us to lead the franchise group given his track record of successfully developing and implementing programs and processes to drive revenue in the healthcare diagnostics industry”.
On joining the ARCpoint team Mr. Mann said, “I couldn’t be more excited to work with this team and group of owners. We are focused on the successful rollout of our new platform which we expect will drive revenue and profitability for our franchisees and our system as a whole. We believe the proprietary nature of the platform gives our owners a unique advantage and ARCpoint a unique value as a company.“
About Bob Mann
Mr. Mann started his diagnostics career at Quest Diagnostics in 2006 as a Sales Manager for Quest’s NC and SC sales teams before taking on different roles including: leading new business acquisition, developing strategies for growth and working with health plans and large healthcare entities. In 2012, he joined Cordant Health Solutions, then known as Sterling Healthcare, which went on to acquire five laboratories and six pharmacies to grow into one of the leading toxicology labs and behavioral health pharmacies in the US. For the past 8 years, Mr. Mann served as part of Cordant’s Executive Leadership team and held several key roles, including as Executive Vice President of Cordant’s Integrated Services group and overseeing sales and strategy. He was instrumental in the development of many of Cordant’s strategic toxicology and pharmacy offerings and also led the development of Cordant’s novel behavioral health pharmacy program that integrated laboratory and pharmacy services.
About ARCpoint Inc.
ARCpoint is a leading US-based franchise system providing drug and alcohol testing, DNA and clinical lab testing, corporate wellness programs, and employment background screening, among other services. The Company is based in Greenville, South Carolina, USA. ARCpoint Franchise Group LLC, (“AFG”) formed under the laws of the state of South Carolina in February 2005, is the franchisor of ARCpoint Labs and supports over 130 independently owned locations. ARCpoint sells franchises to individuals throughout the United States and provides support in the form of marketing, technology and training to new franchisees. ARCpoint Corporate Labs LLC develops corporate-owned labs committed to providing accurate, cost-effective solutions for customers, businesses and physicians. AFG Services LLC serves as the innovation center of the ARCpoint group of companies as it builds a proprietary technology platform and a physician network to equip all ARCpoint labs with best-in-class tools and solutions to better serve their customers. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing and physician services for ARCpoint franchise labs and other clients.
For more information, please contact:
ARCpoint Inc.
Jason Tong, Chief Financial Officer
Phone: (604) 889-7827
E-mail: invest@arcpointlabs.com
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains “forward-looking statements” or “forward-looking information” (collectively referred to hereafter as “forward-looking statements”) within the meaning of applicable Canadian securities legislation.
All statements that address activities, events or developments that ARCpoint expects or anticipates will, or may, occur in the future, including statements about ARCpoint’s future growth, business prospects, future trends, plans and strategies, expected benefits from business activities and the Company’s prospects for new business are forward-looking statements. In some cases, forward-looking statements are preceded by, followed by or include words such as “may”, “will”, “would”, “could”, “should”, “believes”, “estimates”, “projects”, “potential”, “expects”, “plans”, “intends”, “proposes”, “anticipates”, “targeted”, “continues”, “forecasts”, “designed”, “goal”, or the negative of those words or other similar or comparable words. Although the management of ARCpoint believes that the assumptions made and the expectations represented by such statements are reasonable.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of ARCpoint to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Risks and uncertainties applicable to the Company, as well as trends identified by the Company affecting it and the healthcare services industry can be found in the Company’s 2022 Annual MD&A and its continuous disclosure record available on SEDAR. Although ARCpoint has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated, or intended. Forward-looking information included in this press release includes, but is not limited to, statements in respect of the expected timeline for deploying ARCpoint’s online portals and the expected benefits of such online portals.
Such cautionary statements qualify all forward-looking statements made in this press release. ARCpoint undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Any forward-looking information speaks only as of the date on which it is made, and except as required by law, the Company does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for the Company to predict all such factors. When considering the forward-looking information contained herein, readers should keep in mind the risk factors and other cautionary statements in the Company’s disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.
